We, therefore, tested if combined inhibition of MEN1 (MI-503 or VTP50469) and EZH2 (EPZ-6438) could result in synergistic effects on tumor transcriptome and growth in vitro and in vivo. The gene discussed is MEN1; the disease is neoplasm.